High-precision CRISPR-Cas9 base editors with minimized bystander and off-target mutations
Jason M. Gehrke, Oliver Cervantes, Kendell ClementiD, Luca PinelloiD, J. Keith JoungiD
Abstract
Recently described base editor (BE) technology, which uses CRISPR-Cas9 to direct cytidine deaminase enzymatic activity to specific genomic loci, enables the highly efficient introduction of precise cytidine-to-thymidine (C [->] T) DNA alterations in many different cell types and organisms1-6. In contrast to genome-editing nucleases7-9, BEs avoid the need to introduce double-strand breaks or exogenous donor DNA templates and induce lower levels of unwanted variable-length insertion/deletion mutations (indels)1,2,10. However, existing BEs can also efficiently create unwanted C to T alterations when more than one C is present within the five base pair \"editing window\" of these proteins, a lack of precision that can cause potentially deleterious by ...
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CRISPR adenine and cytosine base editors with reduced RNA off-target activities
Julian Grünewald, Ronghao Zhou, … J. Keith Joung·Nature BiotechnologyPeer-reviewed·Sep 1, 2019
- A single CRISPR base editor to induce simultaneous C-to-T and A-to-G mutations
R. C. Sakata, S. Ishiguro, … N. Yachie·bioRxiv·Aug 8, 2019
- Next-generation cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity
Yi Yu, Thomas Leete, … Nicole M. Gaudelli·Nature CommunicationsPeer-reviewed·Apr 28, 2020
- Base editing in Streptomyces with Cas9-deaminase fusions
- Highly precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions
Zhiquan Liu, Siyu Chen, … Zhanjun Li·BMC BiologyPeer-reviewed·Aug 31, 2020
- Base editing generates substantial off-target single nucleotide variants